Notice on Annual General Meeting of Shareholders of AB

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
Notice on Annual General Meeting of Shareholders of AB Linas Agro Group

Hereby we announce the Annual General Meeting of Shareholders (hereinafter – the Meeting) of AB Linas Agro Group, registered address Smėlynės St. 2C, Panevėžys, Lithuania, code 148030011, (hereinafter – the Company) is convened.

The date, time and venue of the Meeting – 27 October, 2016 at 10.00 a.m., Hotel “Smėlynė”, Conference Hall (Smėlynės St. 3, Panevėžys, Lithuania).

Accounting day of the Meeting is 20 October, 2016. Only the persons who are the shareholders of the Company at the end of the Accounting day of the Meeting shall have the right to attend and vote at the Meeting.

The Rights Accounting day is 11 November, 2016. Only the persons who are the shareholders of the Company at the end of the Rights Accounting day shall have proprietary rights.

Agenda of the Meeting:

1.      Presentation of the Company’s Audit committee activity report.

2.      Presentation of the independent auditors’ report.

3.      Presentation of the consolidated annual report of the Company for the financial year 2015/2016.

4.      Approval of the consolidated and the Company‘s set of financial statements for the financial year ended 30 June, 2016.

5.      Approval of the payment of bonuses to the members of the Board of the Company.

6.      Approval of the Distribution of the Company‘s profit.

7.      Election of the Company‘s auditor for the financial year 2016/2017 of the Company and establishment of the payment for the services.

8.      Election of the Company’s Board members.

Initiator of convening of the Meeting is the Board of the Company.

The Meeting is convened by the decision of the Board of the Company, adopted on 4 October, 2016.

Registration of the Shareholders of the Company starts: 27 October, 2016 at 9.15 a.m.

Registration of the Shareholders of the Company ends: 27 October, 2016 at 9.55 a.m.

The Company does not provide possibility to attend and vote at the Meeting through electronic means of communication.

The persons who are shareholders of the Company at the end of the Accounting day of the Meeting shall have the right to attend and vote at the Meeting in person either persons authorized by them, or persons, who concluded an agreement on the disposal of the voting right.

A person attending the Meeting must submit a person’s identification document. A person who is not a shareholder must additionally produce a document confirming his/her right to vote at the Meeting.

Each shareholder shall have a right in the manner established by the Laws to authorize natural or legal person on his/her behalf to attend and vote at the Meeting. At the Meeting an authorized person has the same rights as would be held by the shareholder represented by him/her, unless in the issued power of attorney are indicated otherwise. A power of attorney issued abroad must be translated into Lithuanian and legalized in the manner established by the Laws. The Company does not establish special form of power of attorney.

The agenda of the Meeting may be supplemented by initiative of the shareholders holding shares carrying at least 1/20 of all the votes. The drafts of proposed decisions on proposed issues or, if the decision shall not be adopted, explanation on each proposed issue of the agenda of the Meeting shall be presented alongside with the proposal to supplement the agenda of the Meeting.

The proposal to supplement the agenda shall be submitted in writing by sending it by registered mail to AB Linas Agro Group at the address Smėlynės St. 2C, Panevėžys, Lithuania or by e-mail group@linasagro.lt. The agenda of the Meeting shall be supplemented if the proposal is received not later than 14 days before the Meeting.

The shareholders who own shares carrying at least 1/20 of all the votes shall have the right at any time before the Meeting or during the Meeting to propose new draft decisions on the issue already included or to be included in to the agenda of the Meeting.

The proposed draft decisions must be presented in writing by sending them by registered mail to AB Linas Agro Group at the address Smėlynės St. 2C, Panevėžys, Lithuania or by e-mail group@linasagro.lt. The shareholders shall also be entitled to propose draft decisions on the agenda issues of the Meeting in writing during the Meeting.

The shareholders shall have the right to present questions related to the agenda issues of the Meeting to the Company. The questions in writing can be presented not later than 3 working days before the Meeting, by providing the shareholder’s personal identification number and consent to process personal data – personal identification number by e-mail group@linasagro.lt or delivered to AB Linas Agro Group at the address Smėlynės St. 2C, Panevėžys, Lithuania. Responses of general character shall be posted on the Company’s website www.linasagro.lt. The Company will not respond to the shareholder personally if the respective information is posted on the Company’s website.

A shareholder or a person authorized by him/her shall have right to vote in writing in advance by filling in the General Voting Ballot. Upon a written request of the shareholders holding the voting right, the Company not later than 10 days before the Meeting shall send the General Voting Ballot by registered mail or present personally against acknowledgement of receipt at the registered office of the Company. The General Voting Ballot is also provided on the Company’s website www.linasagro.lt. The filled in General Voting Ballot must be signed by the shareholder or by the person authorized by him/her. If the person who is authorized by the shareholder is voting, the document confirming the voting right must be attached to the filled in General Voting Ballot. The document confirming the voting right must be in Lithuanian or translated into Lithuanian by authorized translator and his/her signature must be confirmed by notarius. Filled in General Voting Ballot and the document confirming the voting right must be submitted to the Company in writing not later than on the last business day before the Meeting, by sending it by registered mail to AB Linas Agro Group at the address Smėlynės St. 2C, Panevėžys, Lithuania or personally to the Company against acknowledgement of receipt.

The shareholders can familiarize with the documents, related to the agenda of the Meeting, draft decisions of each issue of the agenda, documents to be submitted to the Meeting, other information regarding execution of the shareholders rights, in the website of the Company www.linasagro.lt, also at the Company’s office during business days from 8.00 a.m. till 12.00 a.m. and from 1.00 p.m. till 5.00 p.m.

On the day the Meeting is convened the total number of the Company's shares is 158,940,398, and the number of shares granting voting rights is 158,157,426. The own shares in amount of 782,972 acquired by the Company do not grant voting rights. The ISIN code of the Company's shares is LT0000128092.

Sincerely

Chairman of the Board

Darius Zubas

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Apalutamide Boosts Outlook for Prostate Cancer Treatment

Updated Category News Views 81

Fresh Findings on High-Risk Prostate Cancer Treatments In an industry that often feels like a game of chess, Johnson & Johnson's recent news unveils another one of their strategic moves with the announcement of breakthrough results from their Phase 3 PROTEUS substudy. Turns out, ERLEADA®, their apalutamide treatment, isn't just another pawn; it's a potential...

Continue Reading
What to Expect: Your First Therapy Session Insights

Updated Category News Views 169

Starting With the Unknown: The Therapy Journey Begins Rolling into that first therapy session can feel like walking into a mystery with no clues. You're not alone if it stirs up some nerves—most folks feel the same, especially when it's your first rodeo in mental health support. That's where Cody Luke and David Spencer of Luke and Spencer Behavioral Health, based out in...

Continue Reading
Aluminum Design Fumble: Geometry Over Wall Thickness

Updated Category News Views 194

A Misstep in Aluminum Design Practices Well, here's a nugget of wisdom for the metal enthusiasts out there—stop beefing up aluminum components with thicker walls and focus on smart geometry. This isn't a drill, folks. Mark Coyle, a seasoned mind over at American Custom Metals, has been waving the flag for smarter aluminum design methods right from Rochester, NY, and...

Continue Reading
Innovent's IBI354: New Data Spurs Hope for HER2+ BC

Updated Category News Views 0

Innovent Lauds HER2 ADC's Moment at ESMO 2026 Alright, chin up, investors. At the 2026 ESMO Congress, Innovent's throwing down some promising Phase 2 data for their brainchild, IBI354. You hear that name and it's like hearing about a rock star in the making in the oncology world. The potential here isn’t just talk—it's a loud, resounding call for attention. Their...

Continue Reading
CSTS Unveils PremierX in NYC: A Bold Entertainment Move

Updated Category News Views 204

Welcome to the New Era of Entertainment Out of the blockbusters and into the open air, eh? On October 30, 2026, CSTS Enterprises flipped the New York skyline into a canvas for their grand kickoff of PremierXTM—a live entertainment brand poised to redefine how we gobble up our music, sport, and art. Now, there's a shot of adrenaline New Yorkers weren't exactly begging...

Continue Reading
DIRECTV Bags New NHL Deals: Stakes for Sports Fans

Updated Category News Views 229

NHL Fans, Strap in: DIRECTV Expands Its Lineup In a world where keeping up with your favorite team gets tougher each day, DIRECTV just lobbed a puck right into the net with their latest play. They've snagged a multi-year deal with the NHL for the Carolina Hurricanes, Columbus Blue Jackets, Minnesota Wild, and St. Louis Blues networks. It's a game changer, folks. If you...

Continue Reading
Likang's Bold Move: Cancer Immunotherapy at AD Summit

Updated Category News Views 134

Cancer Care Takes Center Stage Kicking off with a bang in Abu Dhabi, Likang Life Sciences has made a splash in the world of personalized cancer immunotherapy. The Abu Dhabi Future Health Summit 2026 served as the backdrop for this bold move, lighting up discussions with their AI-enabled innovations. Likang's showing at the Summit wasn't just another walk in the park—it...

Continue Reading
Master Sommeliers and Italian Producers Clash on Wine Lists

Updated Category News Views 147

Wines Jockeying for New York’s Coveted Lists Alright, picture a stage set up in New York City like an arena. But instead of gladiators, you've got master sommeliers on one side and Italian wine producers on the other, each armed with their own arguments. They're locked in a battle over what it really takes to get a bottle imbedded on a New York City's prestigious wine...

Continue Reading
Axon Body 5: A Leap Forward in AI for Public Safety

Updated Category News Views 270

Axon Raises the Stakes with Body 5 Camera Boy, oh boy, Axon's dropped a bombshell with the Body 5. We're talking a colossal leap into the AI era for public safety, and if you're in the biz, you can't just shrug this one off. We're looking at 25 times the AI processing power compared to Axon's old units. That's right, I said twenty-five. Real-time situational awareness in...

Continue Reading
Alaska's Insurance Maze: Coverage Over Cheap Policies

Updated Category News Views 138

Beyond Premiums: Assessing Real Coverage Needs The Alaskan wilderness isn't just home to stunning views; it's also a land where insurance needs to go beyond the average cookie-cutter policy. You'd think the cheapest option would suffice, but that's where residents might trip into financial quicksand. Devery Prince, a seasoned insurance principal, sheds light on why...

Continue Reading

Top 5 Most Recently Viewed Articles

Container Store Group Faces Delisting by NYSE Amid Market Challenges

Updated Category News Views 145

Container Store Group's NYSE Delisting Announcement The New York Stock Exchange (NYSE) has made a significant announcement regarding the trading status of The Container Store Group, Inc. (TCS). The Exchange's staff has determined that it will initiate proceedings to delist the Company's common stock. This decision comes in light of the Company's recent performance in the...

Continue Reading
Investing in Vanguard Russell 2000 ETF: A Strategic Approach

Updated Category News Views 200

Investing in the Vanguard Russell 2000 ETF: A Strategic Approach In recent years, the stock market's performance has been largely driven by large corporations. While megacap tech stocks have thrived, small-cap stocks have struggled to keep pace. This has resulted in significant valuation discounts for smaller companies compared to their larger peers. Over the past five...

Continue Reading
Welcoming Ann Dunkin to Our Esteemed Board of Directors

Updated Category News Views 156

Ann Dunkin Joins Our Board of Directors We are thrilled to announce the appointment of Ann Dunkin, P.E., to our Board of Directors. With an extensive background in engineering and a strong commitment to public service, Ann's diverse expertise will be invaluable as we navigate the challenges and opportunities in our industry. Professional Background of Ann Dunkin Ann...

Continue Reading
Management Trading Insights on Unexpected Developments

Updated Category News Views 150

Understanding Management Trading Activities When assessing a company's health and future prospects, observing management trading can provide invaluable insights. Executive transactions—buying or selling shares—often reflect their confidence in the business's performance. An increase in stock purchases by management usually signals optimism, while significant sales may...

Continue Reading
Tovecimig's Efficacy in Biliary Tract Cancer Study Unveiled

Updated Category News Views 254

Breakthrough Findings in Biliary Tract Cancer Treatment Compass Therapeutics, Inc. has announced promising interim results from their ongoing Phase 2/3 study, COMPANION-002, examining the efficacy of tovecimig, formerly known as CTX-009, in combination with paclitaxel for treating advanced biliary tract cancer (BTC). Tovecimig, a bispecific antibody targeting both DLL4...

Continue Reading